Financials
- Market Capitalization 232.74 M
- Employee 122
- Founded 2020
- CEO N/A
- Website www.invivyd.com
- Headquarter Delaware, United States
- FIGI BBG00W4ML039
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-8.23
売上高対価格比率
7.96
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 3518 | FULC Fulcrum Therapeutics, Inc. - Common Stock | 3.54 USD | +1.14% | -4.84% | -1.39% | -55.30% | 235.88 M USD | ||
| 3521 | TARA Protara Therapeutics, Inc. - Common Stock | 4.18 USD | -3.24% | +2.20% | +6.09% | +31.45% | 234.93 M USD | ||
| 3542 | OBIO Orchestra BioMed Holdings, Inc. - Ordinary Shares | 3.82 USD | -4.26% | -7.28% | -7.28% | +25.66% | 228.74 M USD | ||
| 3547 | KPTI Karyopharm Therapeutics Inc. - Common Stock | 10.05 USD | -2.80% | +4.91% | +4.15% | +4.25% | 227.76 M USD |